[HTML][HTML] Uremic toxins: an alarming danger concerning the cardiovascular system
CA Falconi, CVC Junho, F Fogaça-Ruiz… - Frontiers in …, 2021 - frontiersin.org
The kidneys and heart share functions with the common goal of maintaining homeostasis.
When kidney injury occurs, many compounds, the so-called “uremic retention solutes” or …
When kidney injury occurs, many compounds, the so-called “uremic retention solutes” or …
The role of phosphate in kidney disease
MG Vervloet, S Sezer, ZA Massy, L Johansson… - Nature Reviews …, 2017 - nature.com
The importance of phosphate homeostasis in chronic kidney disease (CKD) has been
recognized for decades, but novel insights—which are frequently relevant to everyday …
recognized for decades, but novel insights—which are frequently relevant to everyday …
[HTML][HTML] The intestinal microbiota and metabolites in the gut-kidney-heart axis of chronic kidney disease
Y Huang, W Xin, J Xiong, M Yao, B Zhang… - Frontiers in …, 2022 - frontiersin.org
Emerging evidences demonstrate the involvement of gut microbiota in the progression of
chronic kidney disease (CKD) and CKD-associated complications including cardiovascular …
chronic kidney disease (CKD) and CKD-associated complications including cardiovascular …
Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease
JJ Scialla, M Wolf - Nature Reviews Nephrology, 2014 - nature.com
Disturbances in phosphate homeostasis are common in patients with chronic kidney
disease. As kidney function declines, circulating concentrations of phosphate and the …
disease. As kidney function declines, circulating concentrations of phosphate and the …
[HTML][HTML] IRF1-mediated downregulation of PGC1α contributes to cardiorenal syndrome type 4
Y Huang, S Wang, J Zhou, Y Liu, C Du, K Yang… - Nature …, 2020 - nature.com
Abstract Cardiorenal syndrome type 4 (CRS4) is a common complication of chronic kidney
disease (CKD), but the pathogenic mechanisms remain elusive. Here we report that …
disease (CKD), but the pathogenic mechanisms remain elusive. Here we report that …
[HTML][HTML] Uremic toxins and vascular dysfunction
I Six, N Flissi, G Lenglet, L Louvet, S Kamel, M Gallet… - Toxins, 2020 - mdpi.com
Vascular dysfunction is an essential element found in many cardiovascular pathologies and
in pathologies that have a cardiovascular impact such as chronic kidney disease (CKD) …
in pathologies that have a cardiovascular impact such as chronic kidney disease (CKD) …
[HTML][HTML] How do uremic toxins affect the endothelium?
Uremic toxins can induce endothelial dysfunction in patients with chronic kidney disease
(CKD). Indeed, the structure of the endothelial monolayer is damaged in CKD, and studies …
(CKD). Indeed, the structure of the endothelial monolayer is damaged in CKD, and studies …
[HTML][HTML] A systematic review and meta-analysis of murine models of uremic cardiomyopathy
Chronic kidney disease (CKD) triggers the risk of developing uremic cardiomyopathy as
characterized by cardiac hypertrophy, fibrosis and functional impairment. Traditionally …
characterized by cardiac hypertrophy, fibrosis and functional impairment. Traditionally …
[HTML][HTML] Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication
J Kristoff, G Haret-Richter, D Ma… - The Journal of …, 2014 - Am Soc Clin Investig
Damage to the intestinal mucosa results in the translocation of microbes from the intestinal
lumen into the circulation. Microbial translocation has been proposed to trigger immune …
lumen into the circulation. Microbial translocation has been proposed to trigger immune …
[HTML][HTML] A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum
Calciprotein particles, nanoscale aggregates of insoluble mineral and binding proteins,
have emerged as potential mediators of phosphate toxicity in patients with Chronic Kidney …
have emerged as potential mediators of phosphate toxicity in patients with Chronic Kidney …